Home Traction Devices - Cervical and Lumbar - (CPG265) | CIGNA Coverage Update

TL;DR: Cigna Healthcare modified CPG265 (cpg265_home_traction_device) covering home cervical and lumbar traction devices, effective September 26, 2025. All eight HCPCS codes — E0830, E0840, E0849, E0850, E0855, E0856, E0860, and E0941 — are classified as Experimental, Investigational, and/or Unproven. If your practice or DME supplier bills these codes to Cigna, expect denials.

This Cigna home traction device coverage policy is a blanket non-coverage position. There are no covered indications, no prior authorization pathway that unlocks reimbursement, and no clinical criteria that make these devices billable under cpg265 in the Cigna system. The policy covers every category of home traction equipment — overdoor cervical units, pneumatic devices, gravity-assisted frames, inflatable air bladder collars, and freestanding stands. If you bill home traction billing codes to Cigna, the policy now tells you exactly where those claims land.

Quick-Reference Table

Cigna Home Traction Device Coverage Criteria and Medical Necessity Requirements 2025

The short answer on medical necessity under this Cigna home traction device coverage policy: it doesn't apply. Cigna deems all home traction devices Experimental, Investigational, and/or Unproven. You cannot satisfy a medical necessity threshold that the payer has defined as non-existent for home use.

The policy does acknowledge the clinical rationale for traction. Cervical and lumbar traction have historically been used to treat radiculopathy from herniated disc, narrowing of the intervertebral foramen, degenerative nerve root impingement, and spondylolisthesis. Treatment plans are typically short-term — under eight weeks — with sessions two to three times per week. Cigna isn't disputing the theoretical mechanism. They're disputing the evidence that home delivery of that mechanism works.

The policy identifies two proposed mechanisms: biomechanical effects (separation of the intervertebral motion segment, reduced disc protrusion, decreased mechanical stress) and neurophysiological effects (modulation of nociceptive input, silencing of ectopic impulse generators). Cigna's position is that these proposed mechanisms have not been supported by sufficient empirical evidence in the home setting.

Two additional factors drive the non-coverage position. First, the absence of professional supervision at home reduces confidence that correct force and pull angle will be maintained consistently. Second, patient compliance with home-based traction hasn't been well studied, and there's little evidence on how to fix compliance problems when they occur. These aren't minor footnotes — they're the foundation of Cigna's argument that clinical effectiveness in the office doesn't translate to the home.

The real problem for your billing team is that this coverage policy doesn't create a path for exceptions. There's no documentation set, no prior authorization appeal track, and no clinical criteria checklist that moves a home traction claim from denied to paid. The absence of a coverage pathway is the policy.

Cigna Home Traction Device Exclusions and Non-Covered Indications

Every device type in the home traction category is classified as Experimental, Investigational, and/or Unproven under cpg265. This isn't a narrow exclusion for a subset of devices. It's the entire category.

The policy covers all traction types by name: mechanical traction, autotraction, gravity-dependent ("anti-gravity") traction, pneumatic traction, continuous traction, and intermittent traction. Manual traction performed by a clinician in a clinic is outside this policy's scope — CPG265 governs home devices only. But if a patient takes any device home for self-administration, you're in non-covered territory under Cigna's billing guidelines.

There is no clinical condition listed in the policy that makes home traction billable. Radiculopathy, herniated disc, spondylolisthesis, degenerative changes, nerve root impingement — Cigna recognizes these as the target conditions for traction therapy, but that recognition doesn't change the coverage determination. The device goes home and the coverage stops.

Coverage Indications at a Glance

Cigna Home Traction Device Billing Guidelines and Action Items 2025

CPT, HCPCS, and ICD-10 Codes for Home Traction Devices Under cpg265_home_traction_device

CPG265 does not list any covered CPT or HCPCS codes. The policy contains no covered device codes — only codes classified as Experimental, Investigational, and/or Unproven. No ICD-10-CM diagnosis codes are listed in this policy.

Not Covered / Experimental HCPCS Codes

No CPT codes and no ICD-10 codes appear in the CPG265 policy data.

A Note on DME and Other Payer Coverage

CPG265 is a Cigna policy. It does not bind Medicare, Medicaid, or other commercial payers. If your patients have Medicare coverage, home traction durable medical equipment may be subject to a separate local coverage determination from their Medicare Administrative Contractor. Don't assume Cigna's non-coverage position maps to Medicare's. Check the applicable LCD before advising patients on Medicare benefits for these codes.

Cigna's position here is also more restrictive than some other commercial payers. The blanket experimental classification across all eight HCPCS codes — including simple overdoor cervical traction units that cost under $50 retail — reflects Cigna's read of the clinical literature, not a universal industry standard. If your practice sees patients across multiple commercial payers, audit each payer's home traction coverage policy separately.